Credit Suisse has initiated coverage on AbbVie Inc (NYSE: ABBV) with an Outperform rating and a price target of $170. AbbVie stands on the edge of best-selling Humira’s U.S. loss of exclusivity (LOE) in 2023. While this remains the focus of investor discussions, Credit Suisse sees it as a catalyst to push the narrative from a value story to … Read more
Olivier Le Moal Acer Therapeutics (NASDAQ:ACER) said the U.S. Patent and Trademark Office (USPTO) will issue a patent for claims related to certain methods of treating vascular Ehlers-Danlos syndrome (vEDS) with celiprolol. The company added that the patent application No. 16/930,208, exclusively licensed from Assistance Publique—Hôpitaux de Paris, is titled ‘Method of Providing Celiprolol Therapy … Read more
RealVision To Go Too Far or Not Far Enough The market is all set for a 75-basis-point rate-hike in November, though San Francisco Federal Reserve President Mary Daly stoked an equity rally on Friday when she said the central bank should try to avoid an “unforced downturn” by over-tightening. The U.S. dollar softened against major … Read more
mizoula The United Nations-backed Medicines Patent Pool (MPP) said it sign a voluntary licensing agreement with Novartis (NYSE:NVS) to increase access to chronic myeloid leukemia (CML) drug nilotinib, sold as Tasigna. The plan to license the drug was reported earlier this year in May. The MPP said this was the first ever public health-oriented voluntary … Read more
Many of the country’s largest pharmaceutical companies, from Merck & Co. to Bristol Myers Squibb are under pressure to do deals right now because they are staring at huge patent cliffs for their top-selling drugs. For investors considering whether to buy into these companies, figuring out which management teams are going to make the right … Read more
Geeq, a Canada-based blockchain company, has been granted a patent in the United States for features of its multi-blockchain, layer-zero protocol’s security and scalability systems, according to a press release. Details found in the patent’s application describe a technology termed “Proof of Honesty,” which is Geeq’s alternative to predominant proof-of-work and proof-of-stake consensus mechanisms. Additionally, … Read more
Crypto exchange Coinbase has found itself in legal hot water after being accused by blockchain-based software firm Veritaseum Capital of infringing on a patent relating to its blockchain technology — and is now seeking $350 million in damages. According to a lawsuit filed on Thursday by U.S. law firm Brundidge & Stanger in the U.S. … Read more
China accounts for 84% of all blockchain applications filed worldwide, according to the latest data shared by the country’s government official. China has steered clear of the cryptocurrency market. However, the Beijing government has been supportive of the underlying blockchain technology. The country has actively promoted the use of blockchain tech over the years, and … Read more
maybefalse/E+ via Getty Images MediciNova (NASDAQ:MNOV) said it will get a patent from the Canadian Intellectual Property Office which covers MN-001 (tipelukast) and MN-002 (a major metabolite of MN-001) to treat hypertriglyceridemia, hypercholesterolemia, and hyperlipoproteinemia — certain types of metabolic disorders. The patent maturing from this allowed patent application is expected to expire no earlier … Read more
European patent office awards CytRx patent for LADR platform Source link